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Background: The physiological state of the dominant follicle is important as it may be linked to the competence
of the oocyte within. The objective of this study was to analyze, by transcriptomic analysis, the changes occurring
in granulosa cells from dominant follicles at different phases of follicular growth.
Methods: Granulosa cells were collected from slaughterhouse dairy cattle follicles with a diameter greater than
9 mm, and were classified at different phases of follicle growth based on flow cytometry profiles of DNA content
after staining with propidium iodide. Three phases were identified based on the proportion of cells in -G1 (less than
2n DNA), G0-G1 (2n DNA) or S-M (more than 2n DNA) and follicles were thus allocated to the growing, plateau or
atresia group. Between group analysis (BGA) showed clear segregation of the three groups, and the groups were
contrasted against each other in a loop design to identify differently expressed genes. Ingenuity Pathway Analysis
(IPA) was used to identify the functions and upstream regulators associated with the observed differently expressed
genes.
Results: Major differences were observed between the growth phases. Granulosa cells from follicles in the plateau
phase had increased expression of TYRO3 and downregulation of JAM2 compared to growing follicles, supporting
the idea of a shift from proliferation to differentiation. On the other hand, genes regulating the response to
oxidative stress (VNN1) and angiogenesis (ANGPT2) were upregulated in granulosa cells from atretic follicles. While
the predicted activated functions in cells at the plateau stage compared to cells at the growing stage included
synthesis and transport of molecules, the predictions for atretic follicles relative to plateau ones included an
increase in apoptosis and cell death.
Conclusion: Consistent with previous studies, these observations allowed us to match the presence of specific
gene transcripts to a particular physiological status and consequently to classify follicles. The results also
demonstrated that the plateau phase is not a simple ‘in between’ status between growth and atresia, as several
characteristics are unique to this stage.
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Assisted reproductive technologies (ART) are an import-
ant part of reproduction management in humans and
domestic animal species, as both have to cope with fer-
tility problems. The dairy industry faces a decline in
cows’ fertility, which brings additional costs to producers
and lower profits [1]. Our understanding of the under-
lying causes of infertility is growing but many questions
remain unanswered. As the ovarian follicle has a signifi-
cant impact on oocyte quality [2] and the success of
pregnancy, extensive research on follicular development
is needed. The follicle is a dynamic structure and pro-
ceeds towards ovulation or atresia. Although we know
some of the reasons why growth continues or stops,
several key elements of the process remain unknown.
In the cow, the reserve of primordial follicles is esti-
mated at 130,000 at birth [3]. However, most of them
never reach ovulation: more than 99% will undergo atre-
sia [4]. Ovarian follicles will take several months [5] to
go from the primordial stage, which consist of an imma-
ture oocyte covered by a single layer of granulosa cells,
to the antral stage, when the fluid-filled antrum forms.
While activation of primordial follicles’ growth is a
continuous process [6], recruitment of antral follicle
cohorts follows a cyclical pattern. Cohorts are recruited
in a wave-like manner in response to an increase in FSH
levels [7] following either ovulation or regression of
a dominant follicle. In cows, the number of follicles
recruited in a wave varies between 2 and 50 [8] but can
be increased by an artificial exaggeration of the FSH
surge [9]. Selection of the dominant follicle occurs
roughly 2.5 days after the FSH rise, at a diameter of
approximately 8.5 millimetres [10]. FSH levels then drop
and subordinate follicles slow their growth and undergo
atresia, while the dominant follicle enters a phase of
LH-dependent growth. It then reaches a plateau phase
of non-exponential growth [11] with fewer cell divisions
and a slower diameter increase. The presence of pro-
gesterone will determine the fate of this follicle: if this
hormone is absent, the follicle will proceed to ovulation
but if the progesterone level is high, the follicle will enter
atresia [12]. Following the preovulatory LH surge and
ovulation, the follicle undergoes drastic changes to be-
come a highly vascular structure, the corpus luteum [13].
It is known that the developmental competence of the
oocyte changes during the different phases of follicle
development [14,15]. Although one would think that
atresia is detrimental to the oocyte competence, a previ-
ous study has shown that bovine oocytes acquire compe-
tence late in folliculogenesis, during early atresia [16].
The same study suggested that early atresia could mimic
some aspects of the pre-ovulatory environment, increas-
ing the competence of the oocyte. The plateau phase
result in oocytes with a high competence to reach theblastocyste stage [17], while the large growing healthy
follicles have inferior developmental competence [18].
Given the impact of follicular status on oocyte compe-
tence, new tools to classify the follicles and identify the
most physiologically mature ones are highly valuable.
Because different growing phases are associated with
the expression of different genes, transcriptomic analysis
of follicles can provide markers to determine their
physiological status. Previous study on the transcrip-
tomic profiles of granulosa cells revealed several genes
linked to follicular development before establishment of
dominance, and provided tools to classify medium-sized
(6-9 mm) follicles in different growing phases [19].
The main objective of this study was to examine the
transcriptomic profiles of dominant bovine follicles’ granu-
losa cells using microarrays to assess gene pathways
associated with the three stages of follicular growth
identified by flow cytometry (growing (G), plateau (P)
and atretic (A) [20]), and secondary to suggest potential
biomarkers for those stages.
Methods
Granulosa cell collection
Slaughterhouse ovaries from Holstein dairy cattle were
kept on ice during transport and throughout the collec-
tion procedure in order to maintain RNA integrity. Re-
productive status and estrous cycle stage of the animals
are unknown. However, since the follicular waves still
take place when a corpus luteum is present and proges-
terone levels are high, such as during the pregnancy or
during the diestrus, this information is not essential for
the purpose of the project. The growth and the plateau
phases are present in dominant follicles whether proges-
terone is high or not; the only major difference is that in
low progesterone environment, the follicle will become
pre-ovulatory and may reach ovulation. Folliculogenesis
is similar between pregnant and non-pregnant cows
[21], with the only differences appearing around 3 days
prior to ovulation [22] and being attributed to the select-
ive growth and ovulation of the pre-ovulatory follicle in
non-pregnant animals. In cattle, sizes reached by non-
ovulatory dominant follicles are similar to those reached
by ovulatory follicles one day before ovulation [21], and
follicles from the first and second wave have an equivalent
response to superovulation, including similar numbers of
collected embryos [23]. Atretic dominant follicles most
likely come from animals with high progesterone levels.
Otherwise, the follicles would have reached the pre-
ovulatory stage instead of progressing toward atresia.
Collection of the mural granulosa cell layer from indi-
vidual follicles was performed by scraping and measures
were taken to avoid contamination between samples,
following the protocol of Douville et al. [14,19]. Briefly,
the follicle diameter was measured with a ruler at the
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established at approximately 8.5 mm in diameter, only
follicles >9 mm were selected. A portion of the follicular
fluid was aspirated with a syringe and an 18-gauge
needle in order to facilitate scraping. The hole made by
the needle was widened by cutting out a triangular piece
of ovarian epithelium using dissecting scissors. A small,
round weighing spatula was then inserted through the
hole and used to scrape the follicular walls gently to
avoid collecting theca cells or blood contamination.
Granulosa cells from the 27 collected follicles were
transferred to individual 1.5-ml centrifuge tubes contain-
ing 500 μl PBS solution without Ca2+ and Mg2+ (pH of
7.1 recipe (g/L): 0.2 KCL, 0.2 KH2PO4 , 8.0 NaCl, 1.14
Na2HPO4, 1.0 D-glucose (dextrose), 0.11 pyruvate (pyruvic
acid)) passed through 0.22 μm filter and containing
125 mg/L EDTA (PBSE) [20]. The samples were vortexed
gently (half speed for 5 seconds) and centrifuged at 600 ×
g for 30 seconds at 4°C. The supernatants were discarded
to remove cellular debris or blood in the sample leaving
approximately 10 μl in order to not disturb the pellets.
Immediately after supernatant removal, the pellets were
re-suspended by gentle vortexing in 50 μl of the same
cold PBSE solution described above. 25 μl of each of the
50 μl suspensions were transferred to new 750 μl tubes
on ice for propidium iodide (PI) staining and flow
cytometry analysis. The remaining 25 μl was frozen for
RNA extraction.
Flow cytometry
The following procedures were done according to a pre-
viously published protocol [19]. Briefly, 250 μl of PBSE
were added to the 25 μl suspension assigned to cytometry.
Cold 95% EtOH was slowly added to the cell suspensions
while vortexing at half-speed, to attain a final concen-
tration of 70%. To permeabilize cell membranes, these
suspensions were kept at 4°C for a minimum of 16 h. This
allowed the DNA fragments resulting from apoptosis to
exit the cells resulting in a lower DNA content detectable
by flow cytometry [20,24]. All solutions were kept cold to
avoid cell lysis. After centrifugation and removal of the
alcohol containing DNA fragments, the samples were
re-suspended in 500 μl of PI solution (50 μg/ml; Sigma-
Aldrich Canada Ltd., Oakville, ON) in PBSE containing
0.1% Triton X-100 (Sigma-Aldrich Canada Ltd.), and
RNase A (50 μg/ml, Sigma-Aldrich Canada Ltd.) [25].
The subsequent incubation period of 30 min at room
temperature allowed the elimination of RNA by the
RNase. The DNA was left as stained material within the
cells.
Flow cytometry to analyze the DNA content of PI-
stained cells was performed with a Beckman-Coulter
EPICS XL (Mississauga, ON) equipped with a 488 nm
laser. Forward light scatter (FSC) is an indicator of relativeparticle size and side light scatter is an indicator of
granularity. Both were used to gate out debris during
the acquisition process. Peak versus integrated fluores-
cence was used to gate out doublets which are two cells
stuck together. Integrated fluorescence indicates the
time a particle took to pass through the laser for a given
event with two cells stuck together taking longer. Once
the gates had been applied, 10,000 events were acquired.
The fluorescence histograms resulting from flow cy-
tometry were modeled using the FlowJo software. The
model provided the proportion of total events at the
sub-G1 phase (G1-), corresponding to cells with less
than 2n DNA content; at the G1 phase, corresponding
to cells containing 2n of DNA; at the S phase, corre-
sponding to cells that are duplicating their DNA mater-
ial; and at the G2 phase, corresponding to cells having
completely duplicated their genetic material to 4n.
The FlowJo software had its limitations as the model it
applied used approximations and numbers were rounded.
Consequently, the sum of the proportion of cells at each
phase did not add up to exactly 100%, but varied between
92.83% and 110.54% for the samples collected in this
experiment. The proportions were normalized by dividing
the proportion of cells at a given phase by the sum of all
proportions, and multiplying the result by 100.
To categorize the samples obtained from follicles >9 mm
into groups representing physiological status, they were first
ranked in decreasing order using the following formula:
G2þ S þ G1− G1−ð Þ ¼ x
We collected 27 samples from 27 individual follicles
greater than 9 mm in diameter. Two samples were ex-
cluded because of a low RNA integrity number (RIN).
The remaining samples were separated in three groups
based on the x value obtained with the formula above:
seven samples with the highest x value were categorized
as the “growing” (G) group; seven samples with the low-
est x values were categorized as the “atretic” (A) group;
and seven samples with intermediate x values (few
mitosis and limited atresia) were categorized as the
“plateau” (P) group. The four samples remaining which
were at the boundaries between groups were not in-
cluded in the rest of the analysis.
RNA extraction and amplification
Total RNA extraction was performed using the PicoPure
RNA Isolation kit, (Life Technologies Inc., Burlington,
ON) under an RNase-free environment and including a
DNase digestion (Qiagen, Toronto, ON) step. RNA quality
and concentration were verified with a 2100 Bioanalyzer
(Agilent, Santa Clara, CA), using RNA 6000 Nano
reagents (Agilent). All hybridized samples had a RIN
between 7.0 and 9.3. Using 5 ng of extracted total RNA
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fraction was performed using the RiboAmp HSPlus
RNA Amplification Kit (Life Technologies Inc., Bur-
lington, ON) which relies on T7 RNA polymerase
in vitro transcription (IVT) to yield antisense RNA
(aRNA).
Hybridization
Four aRNA samples (out of seven) from each condition
were labelled with either Cy3 or Cy5 dyes using the ULS
Fluorescent Labelling Kit for Agilent arrays (Kreatech
Inc., Durham, NC). The labelled samples (825 ng) were
prepared for hybridization using a Gene Expression
Hybridization Kit (Agilent) step during which the Agi-
lent spike was incorporated. The prepared samples were
then hybridized onto Agilent-manufactured Embryo-
GENE bovine microarray slides [26] in a loop design:
growing against plateau (G vs P), plateau against atresia
(P vs A) and growing against atresia (G vs A). The four
selected granulosa samples originating from individual
follicles in each category were hybridized individually
against the four selected samples of the other categories,
resulting in four biological replicates for each condition.
For each contrast, a second slide was hybridized, inver-
sing the color assigned to each condition, in order to
produce a dye-swap, technical replicate. Hybridization
was performed using Agilent hybridization chambers, in
a rotating oven at 65°C for 17 h. This step was followed by
a three minutes wash with GE Wash Buffer 1 (Agilent) at
room temperature, a three minutes wash with GE Wash
Buffer 2 (Agilent) at 42°C, a ten seconds wash with
acetonitrile at room temperature and a 30 seconds wash
with the Stabilization and Drying Solution at room
temperature. The microarray slides were read by the
Tecan’s PowerScanner with the Autogain procedure on
each individual array. Images were then processed with
Array-Pro Analyzer 6.4 (Media Cybernetics, Rockville,
MD) to map each spot and to manually exclude spots
obstructed by debris such as dust particles.
Microarray statistical snalysis
Expression data was analyzed using the FlexArray soft-
ware version 1.6.1 [27], which is based on the limma
Bioconductor package [28]. Background subtraction
was followed by loess within-array and quantile between-
arrays normalization. The expression data was then
fit to a linear model to estimate fold-changes and an
empirical Bayes procedure was used to produce associ-
ated p-values.
Analysis of differentially expressed genes
Genes to be investigated were selected based on a sym-
metrical raw fold change of 1.5 and a p-value < 0.05. The
contrasts were set up in the following way: G vs P, P vsA and G vs A, where a positive fold change indicated
upregulation in the second item of the contrast.
A between group analysis (BGA) [29] using R software
[30] was performed in order to make a preliminary as-
sessment of the efficiency of flow cytometry to separate
the GC samples in relation to their follicular origin.
Quantitative real-time PCR (qRT-PCR)
Gene expression profiles were validated using qRT-PCR.
All the samples selected for each stage were used, result-
ing in seven biological replicates per category. Therefore,
for each category, qRT-PCR validation was performed
on the four samples selected for hybridization and on
the other three samples best characterizing the given
growth phase, as determined by flow cytometry.
Quantitative RT-PCR was performed on non-amplified
material from all seven samples per group. Total ex-
tracted RNA was reverse transcribed with oligo-dT
primers and the qScript Flex cDNA Synthesis Kit (Quanta
Biosciences, Gaithersburg, MD). Primers specific to the
targeted transcript were designed using PrimerQuest
(Integrated DNA technologies, Coralville, IA). The
qRT-PCR analysis was performed using the LightCycler
480 SYBR Green I Master and the LightCycler 480
System (Roche, Laval, Qc, Cdn). PCR products were
purified with the QIAquick®PCR Purification Kit, and
diluted from 1 × 10−4 ng to 1 × 10−8 ng to calculate a
five-point standard curve in order to quantify the reac-
tion output. Data normalization was performed based
on geNORM normalization [31] using two reference
genes that are well suited for dominant follicles:
eukaryotic translation initiation factor 2B, subunit 2
beta (EIF2B2) and splicing factor 3a, subunit 1 (SF3A1)
[32]. Purified PCR products were sequenced to confirm
specificity. Primer sequences, product sizes, annealing
temperatures, and accession numbers are available in
Additional file 1: Table S1.
qRT-PCR statistical analysis
GraphPad Prism 5.02 (GraphPad Software Inc., San
Diego, CA) was used to perform statistical analysis on
qRT-PCR data. One-tailed t tests were performed to
assess the differences between the samples of each
contrast. A parametric one-way analysis of variance
(ANOVA) was performed with a Newman-Keuls post–
hoc test at a significance level alpha = 0.05. A post-test for
linear trend and a Bartlett’s test for equal variance were
also performed for each set of data. When variances dif-
fered significantly (p-value < 0.05) within a set, the data
were transformed using the equation Y = log (y * 1e12) to
obtain more homogenous variance. A large multiplication
factor was used to obtain values greater than one, as the
logarithm of numbers between 0 and 1 would give a
negative result.
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The Ingenuity Pathway Analysis (IPA) software was used
to further identify functional attributes of the differen-
tially expressed transcripts and to uncover the inte-
ractions between the differentially expressed genes
within the dataset and with other molecules in the IPA
database. The limma data for all 38,732 probes on the
EmbryoGENE bovine array targeting a transcript for
each contrast (G vs P, P vs A and G vs A) were uploaded
as individual dataset into the IPA software. A “core ana-
lysis” was performed separately for each contrast using
default parameters. The cut-off values were set at 1.5
and 0.05 for the fold change and p-value respectively.
The Functions results of the IPA core analysis not only
allowed transcripts to be grouped under particular func-
tional annotations, but were also used to determine
which functions were likely increased or decreased by
integrating the direction of the fold change of a particu-
lar molecule and its documented impact on that func-
tion in the literature. IPA calculates a z-score for each
functional category where a positive z-score predicts that
the biological process is trending towards an increase,
and a negative z-score corresponds to a decreasing
trend. Z-scores ≥ 2 or ≤ −2 indicates that the function’s
trend is statistically significant. The p-value, calculatedFigure 1 Between group analysis (BGA). The analysis was performed wi
three growth stages: Growing (blue), Plateau (green) and Atretic (red). Give
each array, for a total of 8 data sets per growth stage.by Fisher’s Exact Test, measures the likelihood that the
genes in a dataset could be randomly associated to a
given function.
The Upstream analysis section of the core analysis
was used to determine which upstream regulators were
likely activated or inhibited in each contrast. The My
Pathway tool was used to construct gene interaction
networks in a schematic form.
Results
Follicular size
The mean follicular size was not different between the
three groups (ANOVA p–value = 0.845). The means and
standard deviations for the growing, plateau and atretic
groups were 14.9 ± 3.8 mm, 15.4 ± 4.8 and 14.1 ± 3.8 mm,
respectively.
Microarray
The data discussed in this publication have been deposited
in NCBI’s Gene Expression Omnibus [33] and are access-
ible through GEO Series accession numbers GSE63904,
GSE63918 and GSE63919. Between group analysis dem-
onstrated that the samples were segregated into three
distinct groups (Figure 1). The position of the plateau
group between the two other groups on the horizontalth all probes’ data in the green colour, using R software to show the
n the loop design of the experiment, 2 sets of data were available for
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this phase has its own characteristics and is more than a
simple intermediate stage between two physiological states.
A cut-off at a symmetrical fold change of 1.5 and at a
p-value of 0.05 was used after normalisation and resulted
in 761 differentially expressed genes (DEG) between the
growing and the plateau phase, of which 468 were
specific to that transition. Between the plateau and the
atretic phase, 1,709 genes were differentially expressed
with 1,556 of them being specific to that transition.
There were 153 genes modified in both contrasts, but
only 14 of them underwent continuous change between
the three states (Figure 2).
qRT-PCR
The 25 genes selected for quantification by qRT-PCR
were: ACE2, ANGPT2, ANK3, ANKRD1, APOA1, BMP4,
BUB1, CCNB1, CD36, CKS2, JAM2, MT2A, NMB,
NR4A1, NRP1, PRC1, PTTG1, RARRES1, RELN, SER-
PINE1, STAR, TRIB2, TUBB6, TYRO3 and VNN1 (see
Additional file 2: Table S2 for full names). The gene
CYP17A1, which is not expressed in granulosa cells, was
also quantified to assess the potential contamination
with theca cells. The expression level of this gene was
similar in most samples, except for one of the atretic
phase samples (A2) where it was higher, suggesting a
considerable contamination with theca cells. TheFigure 2 Number of differently expressed genes (DEGs). Diagram of th
different expression was defined as a symmetrical fold change of more tha
upregulated genes while green represents downregulated ones. The arrow
same way during all the transitions; the ones in the middle represent the g
(green part) only during one specific transition; the arrows at the bottom r
(from downregulation to upregulation, or vice versa). The numbers accompvariance between the atretic samples was initially signifi-
cantly different (p-value < 0.0001) for the expression
level of CYP17A1 but with the exclusion of sample A2,
the Bartlett’s test for equal variance was not significant
(p-value = 0.5323), showing an improved variance homo-
geneity. Thus, sample A2 was removed from the
analysis.
The expression level of aromatase (CYP19A1) was also
quantified to assess the steroidogenic activity of the
granulosa cells. The mean expression level and variance
was not different at any of the physiological stages (p-
value > 0.1). The homogenous expression level of aroma-
tase suggested that all the samples originated from non
pre-ovulatory follicles [34]. This homogenous expression
of CYP19A1 goes against previous studies, that instead
observed a decrease in atretic follicles [35]. On the other
hand, a sharp decrease in aromatase was also observed
in subordinate follicles when compared to dominant
ones [36], and aromatase activity in dominant atretic
follicles do not decrease as fast as the concentration of
estradiol in follicular fluid [37,38]. Taken together, these
results suggest that dominant follicles may not behave in
the same way as subordinate ones, and that aromatase
activity may not change rapidly enough to give signifi-
cant differences that would better reflect the changes
observed in estradiol concentrations. More studies would
be needed to clarify that point.e number of genes modulated between the growth stages, where a
n 1.5, a minimal intensity of 7 and a p-value < 0.05. Red represents
s at the top of the figure illustrate the genes that are regulated in the
enes that are upregulated (red part of the arrow) or down regulated
epresent the genes that undergo a dramatic shift in their regulation
anying the arrows show the number of genes in each category.
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ized samples and two or three additional samples for
each stage, and the results were compared to the differ-
ences observed with microarray analysis. One-tailed T
tests revealed that among the 25 selected genes, three
(ACE2, NRP1 and TRIB2) had an expression level that
was similar (p-value > 0.1) for all stages. For the G vs
P contrast, three genes (JAM2, TYRO3 and VNN1) had
expression levels that were significantly different (p-value
< 0.05) between the two stages, while the expression level
of seven genes (APOA1, RARRES1, STAR, BMP4, NR4A1,
SERPINE and MT2A) tended to be different (p-value <
0.1). For the P vs A contrast, nine genes (ANGPT2,
CCNB1, CD36, JAM2, PRC1, TYRO3, VNN1, PTTG1 and
BUB1) had expression levels that were significantly differ-
ent (p-value < 0.05) and four genes (CKS2, TUBB6, NMB
and BMP4) had expression levels that tended to be differ-
ent (p-value < 0.1). For the last contrast, G vs A, ten genes
(ANGPT2, ANK3, CCNB1, CD36, CKS2, PRC1, VNN1,
PTTG1, TUBB6 and BUB1) had significantly different
expression levels (p-value < 0.05) and three genes (NMB,
RARRES1, MT2A) tended to have different (p-value <
0.01) expression profiles. Three genes (ANGPT2, CD36
and VNN1) had an expression pattern that increased
across the stages in a linear way (p-value < 0.05) and four
genes (CCNB1, PRC1, PTTG1 and BUB1) had an ex-
pression pattern that decreased in a linear way (p-value
< 0.05). The expression level of the gene RELN was un-
detectable in four out of seven samples of the growing
stage, while it was present in all the other samples.
Transcripts for ANKRD1 were found in five out of seven
samples at the growing stage, in six out of seven at the
plateau stage and in five out of six samples at the atretic
stage. All the differences cited above were in accordance
with the microarray profiles, but the levels of signifi-
cance observed in the microarrays were not confirmed
in the qRT-qPCR data due to the difference of power
between the two methods with four and seven samples
(Figure 3, Additional file 3: Figure S1 and Additional
file 4: Figure S2).
Functions
Using the datasets of modulated genes from the different
contrasts, IPA Functions analysis generated statistically
significant predictions for increased (z-score > 2) or de-
creased (z-score < −2) activity in several cellular functions.
In the transition from G to P, 51 functions were predicted
to be increased. Those functions were mostly related to cell
death and survival, cellular movement, inflammatory re-
sponse, metabolism and transport. The only decreased
function in the contrast between G and P was related to
cell morphology. For the contrast between P and A,
56 functions were predicted to be decreased. Among
them were functions related to cardiovascular systemdevelopment and function, cell death and survival,
cellular assembly and organization, cell development,
cellular movement and cell growth and proliferation.
The 14 increased functions in the atretic phase in con-
trast to the plateau phase were related to cell death and
survival, inflammatory response, metabolism and cell
cycle (ploidy). (Additional file 5: Table S3).
Upstream regulators
For the G vs P contrast, significant activation (z-score > 2)
of 23 upstream regulators was predicted. Those regulators
included several chemical drugs, cytokines, growth factors
and transcription factors. In the same contrast, five up-
stream regulators were predicted to be inhibited. Among
them was a chemical product, enzymes and a transcription
regulator. The change observed in the contrast between
the plateau phase and the atretic phase was more drastic:
147 upstream regulators were predicted to be inhibited,
while 61 were activated. The list of inhibited regulators in-
cluded but was not limited to: chemical drugs or products,
cytokines, enzymes, growth factors, kinases and transcrip-
tion regulators. The list of activated upstream regulator
for the P vs A contrast included chemical drugs or
products, mature microRNAs and transcription regula-
tors. IL-6 and Alpha catenin were two of the most rele-
vant upstream regulators, as they were important in
both contrasts (Figure 4). A selection of the upstream
regulators with the strongest predictions is listed in
Additional file 6: Table S4, and the most relevant will be
discussed in a subsection in the discussion.
Discussion
This study was the first to characterise transcriptomic
profiles of granulosa cells obtained from follicles at dif-
ferent stages of dominance and obtained by objective
flow cytometric analysis. The Between Group Analysis
of the microarray data resulted in clear segregation of
the three physiological states: growth, plateau and atresia
which confirmed the value of the method developed by
Blondin et al. [20] to identify follicular atresia. The
segregation of the samples in three distinct clusters indi-
cated that the stages are physiologically different, and
the absence of a common axis between the three clusters
supported the idea that the transition is not a linear
process. As follicles go through the stages, some genes
are activated while others are inactivated, instead of a
continuous progression toward atresia. A similar segre-
gation was observed in bovine follicles of 6 to 9 mm in
diameter [19], supporting the assumption that the three
different physiological states (growth, plateau and atresia)
are present throughout the antral phase of folliculogenesis.
The physiological difference between these growth stages
was confirmed by the number of differentially expressed
genes observed in each contrast. The small number of
Figure 3 (See legend on next page.)
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Figure 3 Graphs of gene expression profiles showing a significant difference. Twelve genes measured by qRT-PCR in the growing (white
box; n = 7), plateau (grey box; n = 7) and atretic (black box; n = 6) follicles had significantly different expression levels (p-value < 0.05). Significantly
different levels correspond to different letters above the bars. Error bars represent standard deviation (SD). The grey line above the boxes shows
the corresponding microarray hybridization profiles. ANGPT2, Angiopoietin 2; ANK3, Ankyrin 3; BUB1, BUB1 mitotic checkpoint serine/threonine
kinase; CCNB1, Cyclin B1; CD36, Cluster of Differentiation 36 (fatty acid translocase); CKS2, CDC28 protein kinase regulatory subunit 2; JAM2, Junction
adhesion molecule 2; PRC1, Protein regulator of cytokinesis 1; PTTG1, Pituitary tumor-transforming 1; TUBB6, Tubulin, beta 6 class V; TYRO3,
tyrosine-protein kinase receptor TYRO3; VNN1, vanin 1.
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trasts supported the above assumption that these changes
are not linear, but rather really specific to a particular
transformation during follicular development. The Figure 5
represents a simplified representation of the follicle pro-
gression through the growth stages.
The general analysis of gene functions (Additional file 5:
Table S3) indicated that there was a clear rise of cell death
signalling and apoptosis as early as the plateau phase, and
that a decrease of cell viability took place between the
plateau and the atretic stage. This function was associated
with the modulation of several genes in the same direc-
tion, as shown by the z-scores above 2. Simultaneously,
inflammation signalling started to increase in the plateau
phase along with protein synthesis. This represented a
transition from cell division to differentiation, character-
ized by increased lipid metabolism and steroid synthesis
typical of dominant follicles. In the next transition, from
plateau to atresia, many of the genes being shut down
were associated with cancer, cell viability and angiogenesis,
illustrating the growth arrest and non-reversible state of
these follicles. The few functions that were activated in
atresia compared to plateau were cell death-related. In this
case, analysis of individual DEG is a good way to identify
early and late markers of atresia.
Upstream regulators
One of the most powerful tools in Ingenuity Pathway
Analysis is the identification of upstream regulators. The
software categorizes upregulated or downregulated genes
that are in relation with a specific trigger, such as a gene
or a chemical. For example, if tens of genes that nor-
mally respond positively or negatively to estradiol are all
moving in the anticipated direction, this gives a strong
support to a real physiological phenomenon. Additional
file 6: Table S4 documents the importance of certain im-
munomodulators (IL-1, Il-6 and TNF) in the differenti-
ation process [39-41] expected in the plateau phase. In
our data set, numerous genes modulated by IL-6 under-
went opposite changes as the follicles went from grow-
ing to plateau and then from plateau to atresia (Figure 4
A and B), supporting the idea that the physiology of the
plateau phase is different from the other stages. This
molecule plays a role in inflammation [42] and could
potentially be used as an indicator to predict the generalfate of the follicles. The combination of two different
TGFB pathways also supports the shift from growth to
differentiation, as these molecules seem to be important
factors for tissue remodelling during wound healing [43]
and are known to participate in the differentiation of
granulosa cells [44]. On the other hand, the decrease in
expression of c-Myc targets supports the decrease in cell
divisions in this class. In myeloid leukemia cells, the de-
crease of c-Myc has been linked with differentiation [45].
Some upstream regulators suggested for the transition
between the plateau and the atretic phase moved in the
opposite direction of what would be expected in pre-
ovulatory follicles. For example, TGFB1 was predicted to
be downregulated in our atretic follicles; however, it has
been suggested to participate in luteal function [46] and
to have an anti-apoptotic effect in human luteinized
granulosa cells [47].
Alpha catenin is a key element of the cadherin-catenin
protein complex which participates in intercellular adhe-
sion and plays a pivotal role in development [48]. In epi-
thelial cells, alpha catenin is a mediator of cell density
[49] and it has been postulated that it could be part of a
molecular biosensor of cell density and positioning [48].
Over-expression of this gene has been associated with
increased osteoblastic differentiation [50] while reduced
expression was found in highly proliferative and poorly
differentiated lung cancer tumour cells [51]. Administra-
tion of hCG–LH in rats reduced alpha catenin expres-
sion in ovulatory follicles and the authors suggested that
it plays a role in the changes in cell-cell adhesion associ-
ated with ovulation and luteinisation [52]. Our results
support this idea, as the downregulation of alpha catenin
was predicted to be one of the upstream regulators of
the changes in gene expression between the growing and
the plateau phase. Follicles at the plateau phase undergo
changes that prepare them for an eventual ovulation,
and alpha catenin may play a role in this process. On
the other hand, the activation of the same molecule was
proposed as an upstream regulator of the transition from
plateau to atretic follicles. This view is supported by data
from Sanchez et al. who suggested that beta-catenin,
which is closely related to alpha catenin, is involved in
granulosa cell atresia [53]. The shift observed in the
action of genes regulated by alpha catenin as follicles go
from growing to plateau and from plateau to atresia
Figure 4 Upstream regulators of interest. The analysis of genes that are downstream of IL-6 generated highly significant P values for this top
regulator in the contrast Growing vs Plateau (A) and Plateau vs Atresia (B). The same approach also generated highly significant P values for the top
regulator Alpha catenin in the contrast Growing vs Plateau (C) and Plateau vs Atresia (D). A list of abbreviations is provided at the end of the article.
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an initiator of some of the changes occurring during
folliculogenesis.Hepatic growth factor (HGF) has been associated with
increased granulosa cell proliferation in mouse follicles
[54]. It also stimulates bovine granulosa cell proliferation
Figure 5 Schematic representation of the follicle’s progression
through the growth stages. The dominant follicle undergoes three
different growth stages during its development. The growing stage
(yellow portion of the arrow) is characterised by a quick increase in
diameter and the proliferation of granulosa cells. The mitoses slow
down during the plateau phase (orange portion of the arrow), and
the cells start a differentiation process. At this point, the follicle can
take two different paths: progress toward the pre-ovulatory stage
and ovulation (grey portion of the arrow) or become atretic (brown
portion of the arrow), a stage characterised by an increase in apoptosis
and cell death.
Girard et al. Reproductive Biology and Endocrinology  (2015) 13:17 Page 11 of 15in vitro [55] and has anti-apoptotic effects on rat granu-
losa cells in vitro [56]. It has been suggested that HGF
controls theca cell and granulosa cell steroidogenesis
[57], indicating an important role during folliculogenesis.
HGF is an upstream regulator predicted to be downreg-
ulated in our contrast P vs A, which is consistent with
the proliferative and anti-apoptotic effect of that mol-
ecule on granulosa cells. The transition from plateau to
atretic follicles includes an increase in apoptotic events in
granulosa cells and HGF may play a role in this process.
Biomarkers
With the important place taken by reproduction man-
agement in cattle, accessible tools to identify the growth
stages of the follicles would be useful in many situations.
As the physiology and the differentiation of the follicle
can have an important impact on the competence of the
oocyte within [17], the classification of follicles among
the different growth stages may improve the programs
currently used for cattle reproductive management. For
example, Ovsynch is an effective program used to syn-
chronise ovulation in lactating dairy cows, but it is less
effective with heifers [58]. Even among lactating cows,
different pregnancy rates are observed between prim-
iparous and multiparous cows [59]. Those different
success rates could be caused by small differences in fol-
licular development, which are impossible to detect with
current methods. In humans, numerous studies tried to
find a good predictor of oocyte competence in follicular
fluid, but none has yet succeeded (see [60] for a review),
and in cattle, follicular diameter is not always linked
with competence [61]. The results of this project suggest
a list of atresia markers which can be tested in larger
follicles, in order to identify atretic follicles containing
poor quality oocyte.Several biomarker candidates showed no significant
differences between the stages. However, the absence of
significance was often caused by an important standard
deviation in the plateau group. The standard deviation
of seven genes (RARRES1, SERPINE1, STAR, TRIB2,
CYP19A1, APOA1, BMP4), from which several are linked
to LH response [34,62,63] or to progesterone [64,65], was
higher in the plateau group than in the two others. This
may be an indicator of a more diversified population of
follicles. This assumption would be coherent with our
understanding of this particular stage, as we supposed
that the follicles from the plateau phase can take two
directions: proceed toward ovulation or enter atresia.
The physiological differences between those two options
may explain the important variation observed among the
samples of the plateau phase.
Markers of growing follicles
Growing follicles shared many characteristics with the
plateau phase, while some genes had a clear pattern of
change when follicles were moving into atresia. For
example, transcripts for RELN were not found at all
(with PCR) in four out of seven granulosa cell samples
originating from follicles at the growing stage, while they
were found in all the samples from the other categories
in similar quantities (Additional file 4: Figure S2). RELN
is a ligand of the very-low-density lipoprotein receptor
(VLDLR) and has an antiproliferative activity [66]. This
gene had already been associated with the end of follicu-
lar growth [67] and could be used as a marker.
Markers of the plateau phase
Among the tested genes, only a few had an expression
level that was significantly different between the plateau
phase and other phases. Those genes were TYRO3 and
JAM2, which were upregulated and downregulated, re-
spectively. TYRO3 is a receptor of GAS6 (growth arrest
specific 6), and both the receptor and the ligand, were
abundantly expressed in differentiating stem cells [68].
The over expression of the receptor TYRO3 in samples
from the plateau phase is another element that high-
lights the importance of the differentiation process at
that stage of folliculogenesis. JAMs are a family of genes
that encode proteins that are localized at the junctions be-
tween cells. They have multiple functions including angio-
genesis, cell migration and proliferation [69]. Blocking
JAM2 and JAM3 in vitro impaired the growth and inva-
sion of glioma cells [70], and their expression was
increased in tumor cells [71]. The downregulation of
JAM2 observed in the plateau phase is consistent with
the slowing of proliferation. Thus, the expression pat-
terns of TYRO3 and JAM2 in this study support the idea
that the plateau phase is physiologically distinct from
the growing and the atretic phases.
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Several genes were differentially expressed between the
atretic phase and the other phases making them poten-
tial biomarkers. Among them are genes related to
angiogenesis such as ANGPT2 and CD36, which were
over expressed in the atretic group. The status of blood
vessel network is important during folliculogenesis, as
an increased vascularisation is linked with better deliv-
ery of gonadotropins [72] and thecal blood vessel re-
gression is linked with atresia of bovine non-ovulatory
follicles [73]. Both ANGPT2 and CD36 can have anti-
angiogenic effects [74,75]. ANK3 expression was also
significantly higher at the atretic phase compared to the
other phases. This protein participates in the coordin-
ation of cell membrane assembly by interacting with
E-cadherin at contact sites between cells [76] and it has
also been suggested as a marker of senescence in
cultured fibroblast cells [77].
A decreased expression of genes related to cell prolif-
eration (BUB1, CCNB1, CKS2, TUBB6 and PRC1) was
also observed in atretic follicles. BUB1 is a key regulator
of spindle assembly checkpoint and chromosomal segre-
gation during mitosis and meiosis [78]; CCNB1 encodes
for a protein that is essential for cells to enter mitosis
[79]; CKS2 has been suggested to serve as a cell cycle
checkpoint protein for the S/G2 transition [80]; TUBB6
is a minor isoform of tubulin that is essential for cell
cycle [81]; PRC1 helps to control proliferation by regu-
lating DNA replication [82]. The sharp decrease in the
expression of these genes observed in atretic follicles is
consistent with the reduced proliferation that charac-
terises this stage, and suggests that they can be used as
biomarkers to identify follicles committed to atresia.
The linear increase in the expression of VNN1 across
all stages was consistent with the literature, as this tran-
script increased during the coasting period in follicles
[67,83] and had been linked to follicular atresia. VNN1
is an enzyme that regulates the GSH-dependent re-
sponse to oxidative injury, decreases tissue resistance to
oxidative stress [84], and its over expression was consist-
ent with the increase in apoptosis observed during fol-
licular atresia. The progression toward the atretic stage
was also accompanied by a linear decrease of PTTG1,
whose suppression has been linked to increased apop-
tosis [85]. When over expressed, this gene limited the
ability of p53 to induce apoptosis [86].
Conclusion
In conclusion, this project provided valuable clues to the
physiological differences between the three growth
stages of dominant follicles. It led to the identification of
upstream regulators associated with functional changes
that take place during the late development of follicles
such as alpha catenin, HGF, IL-6 and TGFBs. It also shedlight on the principal functions modulated during those
changes and finally, it provided numerous potential bio-
markers to simplify future determination of the growth
stage of follicles.
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